[Hybrid Seminar held on June 6th] Discovery-based paper search AI explores the potential of cancer immunotherapy and exosomes as a biomarker
This time, we will use paper search AI on the theme of "exosomes."
Exosomes are a type of extracellular vesicle with a diameter of 50 to 150 nm. Their surface contains lipids and proteins derived from the cell membrane, and their interior contains intracellular substances such as nucleic acids (microRNA, messenger RNA, DNA, etc.) and proteins.
In recent years, exosomes have attracted attention as carriers of intercellular communication, and are being actively studied in a wide range of fields, including cancer, neurological diseases, and immune responses.
Exosomes in bodily fluids are also expected to be useful in the diagnosis and treatment of diseases, and clinical trials targeting exosomes as drug discovery targets are being conducted around the world.
This time, we will introduce effective ways to use "KIBIT Amanogawa" to obtain research hints through a demonstration of the use of exosomes as a biomarker for prognosis prediction and treatment efficacy assessment in cancer immunotherapy, as well as the possibility of applying them to treatment strategies.
[Date and time] Thursday, November 2025, 6 5:11~40:12
* Demo experience session (real-life venue only): Thursday, July 2025, 6 5:12-30:13 (free to leave)
[Format] Online (Zoom Webinars) & real venue held simultaneously
*Bento and drinks will be provided at the real venue.Please join us as a luncheon seminar.
[Venue] FRONTEO Co., Ltd. Shinagawa Head Office 4th floor AI Tech Lounge
(Address: Meisan Takahama Building, 108-0075-2 Konan, Minato-ku, Tokyo 12-23)
*Capacity: 10 people (first-come, first-served basis. If the capacity is exceeded, you will be placed on a waiting list for cancellations)
[Participation conditions]
We kindly ask that you refrain from applying if you are using the free address, if you are in the same industry as us, or if you do not know your affiliation.When accessing Zoom on the day, please enter your name and email address that you entered at the time of application in the entry field for Zoom participation.
FRONTEO Inc.
Life Science AI Business Headquarters
Sales Team Manager
Keitaro Hagiwara
While studying at Tokyo University of Science, he researched exosomes and the mechanisms of cancer malignancy at the National Cancer Center and obtained a Ph.D. in Science.
He later served as an assistant professor at the University of Occupational and Environmental Health, and as an executive at a number of ventures, including as CTO of Nagoya University Venture Healthcare Systems.
He has also worked at DNP and Aflac subsidiary Hatch Healthcare, where he was involved in launching new healthcare businesses, and is currently working to expand the medical paper search AI system "KIBIT Amanogawa" in the Life Science AI Business Division.
FRONTEO Inc.
KIBIT Solutions Promotion Department
AI Consulting Team Manager
Shuhei Narita
Experienced in physical and chemical analysis in the CMC area, analysis using microorganisms and cells, and biopharmaceutical analysis at a pharmaceutical analysis contract company. After that, he was in charge of business development and POC program manager at CRO, and has a rich track record of formulating business plans and providing consultation from the early stages of drug development to licensing out, mainly for bio-ventures and academia.
He currently works in the KIBIT Solutions Promotion Department at FRONTEO Co., Ltd., and is active as an AI consultant in the medical industry based on his past experience. He provides a wide range of support from the introduction to operation of AI solutions, including the paper search AI system "KIBIT Amanogawa," and is working hard to optimize the use of AI in companies.
Articles in the same category
[Online Seminar held on July 7] New threats in the digital transformation era and their risk management
[Online Seminar held on June 6th] Should Data Be Stored Within the Country?: Cross-border Application of Discovery and Government Access
[Online Seminar Held June 6th] How to Deal with, Utilize, and Apply the Security Clearance System in Companies
[Online Seminar held on June 6th] "Drug Discovery AI Factory" - an AI drug discovery support service that discovers the unknown from the known
[Online seminar held on June 6th] "Awareness-based legal affairs" protect companies ~ Investigation x Reporting Promotion and Control ~ Practical knowledge of "early response to potential problems" that practitioners should know now
[6/11 39th Economic Security Seminar] The Frontline of Economic Security Intelligence: The Path Forward for the Japanese Government and Companies in an Era of International Uncertainty and Trump Tariffs - Based on the Issues of the Revision of METI's "Action Plan for Strengthening the Industrial and Technological Base" -
[Online Seminar held on June 6th] Amendments to the Whistleblower Protection Act of 12 and points to note
[Online Seminar Held on May 5th] Learn from Case Studies! Real Troubles in M&A: Five Lessons Legal Departments Should Learn
[Online seminar held on May 5] "Prevention" and "Response in the event of an emergency" regarding the taking of trade secrets by former employees <22rd of XNUMX-part course> Prevention - Confidentiality management and leak prevention -
